{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:38:53Z","timestamp":1793158733354,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12885-018-4158-3","type":"journal-article","created":{"date-parts":[[2018,3,7]],"date-time":"2018-03-07T06:41:22Z","timestamp":1520404882000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Burden of early, advanced and metastatic breast cancer in The Netherlands"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6846-2752","authenticated-orcid":false,"given":"G. T.","family":"Vondeling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. L.","family":"Menezes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. P.","family":"Dvortsin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. G. A.","family":"Jansman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. R.","family":"Konings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. J.","family":"Postma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. H.","family":"Rozenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,7]]},"reference":[{"issue":"2","key":"4158_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, et al. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69\u201390.","journal-title":"CA Cancer J Clin"},{"key":"4158_CR2","volume-title":"Global Cancer Facts & Figures","author":"AC Society","year":"2012","unstructured":"Society AC. Global Cancer Facts & Figures. 3rd ed; 2012.","edition":"3"},{"issue":"6","key":"4158_CR3","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1016\/j.ejca.2012.12.027","volume":"49","author":"J Ferlay","year":"2013","unstructured":"Ferlay J, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49(6):1374\u2013403.","journal-title":"Eur J Cancer"},{"key":"4158_CR4","volume-title":"GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012","author":"W IARC","year":"2012","unstructured":"IARC, W., GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012. GLOBOCAN, 2012."},{"issue":"2","key":"4158_CR5","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1093\/eurpub\/cku088","volume":"25","author":"D van der Waal","year":"2015","unstructured":"van der Waal D, et al. Breast cancer diagnosis and death in the Netherlands: a changing burden. Eur J Pub Health. 2015;25(2):320\u20134.","journal-title":"Eur J Pub Health"},{"issue":"2","key":"4158_CR6","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1093\/eurpub\/14.2.141","volume":"14","author":"ME Kruijshaar","year":"2004","unstructured":"Kruijshaar ME, Barendregt JJ. The breast cancer related burden of morbidity and mortality in six European countries: the European disability weights project. Eur J Pub Health. 2004;14(2):141\u20136.","journal-title":"Eur J Pub Health"},{"issue":"1","key":"4158_CR7","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s10552-007-9075-8","volume":"19","author":"WJ Louwman","year":"2008","unstructured":"Louwman WJ, et al. On the rising trends of incidence and prognosis for breast cancer patients diagnosed 1975-2004: a long-term population-based study in southeastern Netherlands. Cancer Causes Control. 2008;19(1):97\u2013106.","journal-title":"Cancer Causes Control"},{"issue":"4","key":"4158_CR8","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1001\/jamaoncol.2015.0735","volume":"1","author":"C Fitzmaurice","year":"2015","unstructured":"Fitzmaurice C, et al. The global burden of cancer 2013. JAMA Oncol. 2015;1(4):505\u201327.","journal-title":"JAMA Oncol"},{"key":"4158_CR9","unstructured":"National Institute for Public Health and the Environment \/ Ministry of Health, Welfare and Sport. National Evaluation of breast cancer screening in the Netherlands (facts and figures). \n                    https:\/\/www.rivm.nl\/en\/Documents_and_publications\/Common_and_Present\/Publications\/Disease_prevention_and_healthcare\/breastcancer_screening\/National_evaluation_of_breast_cancer_screening_in_the_Netherlands\n                    \n                  . Accessed 3 Oct 2014."},{"key":"4158_CR10","unstructured":"Integraal Kankercentrum Nederland (IKNL), Dutch cancer registry. Cijfers over kanker. \n                    https:\/\/www.cijfersoverkanker.nl\n                    \n                  . Accessed apr 2017."},{"key":"4158_CR11","unstructured":"James D. Brierley (Editor), Mary K. Gospodarowicz (Editor), Christian Wittekind (Editor). Union for International Cancer Control (UICC). The TNM Classification of Malignant Tumours, 8th Edition. ISBN: 978-1-119-26357-9. Jan 2017, Wiley-Blackwell."},{"key":"4158_CR12","unstructured":"Cancer Research UK. Breast cancer stages types and grades. \n                    http:\/\/www.cancerresearchuk.org\/about-cancer\/breast-cancer\/stages-types-grades\/tnm-staging\n                    \n                  . Accessed Apr 2017."},{"issue":"3","key":"4158_CR13","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/sj.bjc.6603231","volume":"95","author":"I Soerjomataram","year":"2006","unstructured":"Soerjomataram I, et al. Increased risk of second malignancies after in situ breast carcinoma in a population-based registry. Br J Cancer. 2006;95(3):393\u20137.","journal-title":"Br J Cancer"},{"key":"4158_CR14","unstructured":"Knowlegde Institute of Medical Specialist. Richtlijnen database. Guidelines for the treatment of breast cancer in The Netherlands. \n                    https:\/\/richtlijnendatabase.nl\/en\/richtlijn\/breast_cancer\/breast_cancer.html\n                    \n                  . Accessed Apr 2017."},{"key":"4158_CR15","unstructured":"Central Bureau for Statistics (CBS). Lifetable; life expectancy by gender and age in the Netherlands. \n                    http:\/\/statline.cbs.nl\/Statweb\/publication\/?DM=SLNL&PA=37360ned&D1=0&D2=a&D3=a&D4=l&HDR=G1,T&STB=G2,G3&VW=T\n                    \n                  . Accessed Apr 2017."},{"key":"4158_CR16","unstructured":"Minicozzi P, Otter R, Primic-\u017dakelj M, Francisci S. Survival of Cancer Patients in Europe, 1999\u20132007: The EUROCARE-5 Study. European Journal of Cancer. 2015;51(15):2099\u20132268."},{"key":"4158_CR17","unstructured":"Stouthard MEA, Essink-Bot M-L, Bonsel G, Barendregt JJM, Kramers PGN, van de Water HPA, yvan der Maas PJ. Disability Weights for Diseases in the Netherlands. Rotterdam: Department of Public Health, Erasmus University; 1997. \n                    https:\/\/www.researchgate.net\/publication\/254787050_Disability_Weights_for_Diseases_in_The_Netherlands\n                    \n                  ."},{"key":"4158_CR18","unstructured":"Ministry of public health, wellbeing and sport (RIVM). Cost of illness database. \n                    https:\/\/kostenvanziektentool.volksgezondheidenzorg.info\/tool\/nederlands\/?ref=kvz_v2l1b1p4r1c2i0t1j0o1y6a-1g0d14s54z0f0w2\n                    \n                  . Accessed Apr 2017."},{"key":"4158_CR19","unstructured":"Central Bureau for Statistics (CBS). Customer Price Index (CPI) for The Netherlands. \n                    http:\/\/statline.cbs.nl\/StatWeb\/publication\/?VW=T&DM=SLEN&PA=83131ENG&LA=EN\n                    \n                  . Accessed Apr 2017."},{"issue":"3","key":"4158_CR20","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.jval.2011.12.012","volume":"15","author":"P Hanly","year":"2012","unstructured":"Hanly P, et al. Breast and prostate cancer productivity costs: a comparison of the human capital approach and the friction cost approach. Value Health. 2012;15(3):429\u201336.","journal-title":"Value Health"},{"issue":"11","key":"4158_CR21","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1038\/bjc.2013.177","volume":"108","author":"MG Marmot","year":"2013","unstructured":"Marmot MG, et al. The benefits and harms of breast cancer screening: an independent review. Br J Cancer. 2013;108(11):2205\u201340.","journal-title":"Br J Cancer"},{"issue":"21","key":"4158_CR22","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1056\/NEJMoa1206809","volume":"367","author":"A Bleyer","year":"2012","unstructured":"Bleyer A, Welch HG. Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med. 2012;367(21):1998\u20132005.","journal-title":"N Engl J Med"},{"issue":"20","key":"4158_CR23","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1056\/NEJMp1600894","volume":"374","author":"DR Lowy","year":"2016","unstructured":"Lowy DR, Collins FS. Aiming high--changing the trajectory for cancer. N Engl J Med. 2016;374(20):1901\u20134.","journal-title":"N Engl J Med"},{"issue":"9916","key":"4158_CR24","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/S0140-6736(13)62226-6","volume":"383","author":"D Hanahan","year":"2014","unstructured":"Hanahan D. Rethinking the war on cancer. Lancet. 2014;383(9916):558\u201363.","journal-title":"Lancet"},{"issue":"10","key":"4158_CR25","doi-asserted-by":"publisher","first-page":"12941","DOI":"10.1007\/s13277-016-5168-x","volume":"37","author":"O Golubnitschaja","year":"2016","unstructured":"Golubnitschaja O, et al. Breast cancer epidemic in the early twenty-first century: evaluation of risk factors, cumulative questionnaires and recommendations for preventive measures. Tumour Biol. 2016;37(10):12941\u201357.","journal-title":"Tumour Biol"},{"issue":"12","key":"4158_CR26","doi-asserted-by":"publisher","first-page":"2930","DOI":"10.1002\/ijc.26280","volume":"130","author":"S Hofvind","year":"2012","unstructured":"Hofvind S, et al. Breast cancer incidence trends in Norway--explained by hormone therapy or mammographic screening? Int J Cancer. 2012;130(12):2930\u20138.","journal-title":"Int J Cancer"},{"issue":"1","key":"4158_CR27","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/0778-7367-69-2","volume":"69","author":"F Renard","year":"2011","unstructured":"Renard F, Van Eycken L, Arbyn M. High burden of breast cancer in Belgium: recent trends in incidence (1999-2006) and historical trends in mortality (1954-2006). Arch Public Health. 2011;69(1):2\u20132.","journal-title":"Arch Public Health"},{"issue":"22","key":"4158_CR28","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1093\/jnci\/djp358","volume":"101","author":"M Poll\u00e1n","year":"2009","unstructured":"Poll\u00e1n M, et al. Recent changes in breast cancer incidence in Spain, 1980\u20132004. J Natl Cancer Inst. 2009;101(22):1584\u201391.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"4158_CR29","doi-asserted-by":"publisher","first-page":"65","DOI":"10.4103\/0019-509X.112307","volume":"50","author":"SM Balasubramaniam","year":"2013","unstructured":"Balasubramaniam SM, Rotti SB, Vivekanandam S. Risk factors of female breast carcinoma: a case control study at Puducherry. Indian J Cancer. 2013;50(1):65\u201370.","journal-title":"Indian J Cancer"},{"issue":"3","key":"4158_CR30","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1002\/ijc.29272","volume":"137","author":"H Oh","year":"2015","unstructured":"Oh H, et al. The interaction between early-life body size and physical activity on risk of breast cancer. International journal of cancer. Int J Cancer. 2015;137(3):571\u201381.","journal-title":"Int J Cancer"},{"issue":"3","key":"4158_CR31","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1023\/A:1006003110909","volume":"49","author":"BA Stoll","year":"1998","unstructured":"Stoll BA. Western diet, early puberty, and breast cancer risk. Breast Cancer Res Treat. 1998;49(3):187\u201393.","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"4158_CR32","doi-asserted-by":"publisher","first-page":"e60056","DOI":"10.1371\/journal.pone.0060056","volume":"8","author":"H Talma","year":"2013","unstructured":"Talma H, et al. Trends in menarcheal age between 1955 and 2009 in the Netherlands. PLoS One. 2013;8(4):e60056.","journal-title":"PLoS One"},{"issue":"1","key":"4158_CR33","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s10549-015-3447-7","volume":"152","author":"WA van Gemert","year":"2015","unstructured":"van Gemert WA, et al. The proportion of postmenopausal breast cancer cases in the Netherlands attributable to lifestyle-related risk factors. Breast Cancer Res Treat. 2015;152(1):155\u201362.","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"4158_CR34","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1038\/bjc.2013.6","volume":"108","author":"S Walters","year":"2013","unstructured":"Walters S, et al. Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000-2007: a population-based study. Br J Cancer. 2013;108(5):1195\u2013208.","journal-title":"Br J Cancer"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4158-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,6]],"date-time":"2019-03-06T19:16:47Z","timestamp":1551899807000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-018-4158-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,7]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["4158"],"URL":"https:\/\/doi.org\/10.1186\/s12885-018-4158-3","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,7]]},"assertion":[{"value":"27 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"No ethical approval was required as an existing database was used and aggregated data was provided by IKNL.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Mark Rozenbaum is employed by Pfizer. All other authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"262"}}